[Comparative evaluation of the gastric transit of floating and non-floating matrix dosage forms]
- PMID: 2099235
[Comparative evaluation of the gastric transit of floating and non-floating matrix dosage forms]
Abstract
The gastric transit of floating and non-floating matrix dosage forms has been studied by means of a gamma scintigraphic imaging technique. Results indicate that, on the one hand, buoyancy and non-buoyancy of the forms lead to distinct intragastric behaviours and that, on the other hand, a selective gastric retention is operated in function of the diametral size of the matrix. Depending on the subject posture, standing or supine, the gastric residence period of the form is hence determined either by its buoyancy or by its size. As sustained drug delivery systems, the floating dosage forms globally offer several advantages which might be worth taking into account.
Similar articles
-
Gastroretentive dosage forms.Crit Rev Ther Drug Carrier Syst. 1993;10(2):143-95. Crit Rev Ther Drug Carrier Syst. 1993. PMID: 8370085 Review.
-
Specific aspects of gastro-intestinal transit in children for drug delivery design.Int J Pharm. 2010 Aug 16;395(1-2):37-43. doi: 10.1016/j.ijpharm.2010.04.048. Epub 2010 May 15. Int J Pharm. 2010. PMID: 20478372
-
Development and evaluation of new sustained-release floating microspheres.Int J Pharm. 2008 Jun 24;358(1-2):82-90. doi: 10.1016/j.ijpharm.2008.02.024. Epub 2008 Feb 29. Int J Pharm. 2008. PMID: 18407442
-
In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans.Int J Pharm. 2004 May 4;275(1-2):97-107. doi: 10.1016/j.ijpharm.2004.01.036. Int J Pharm. 2004. PMID: 15081141 Clinical Trial.
-
Gastroretentive dosage forms: overview and special case of Helicobacter pylori.J Control Release. 2006 Mar 10;111(1-2):1-18. doi: 10.1016/j.jconrel.2005.10.031. Epub 2006 Jan 5. J Control Release. 2006. PMID: 16403588 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials